Participants wanted for online survey about crowdfunding smaller pharmaceutical companies
30 July 2014
Parkinson's and Alzheimer's disease are the two most common neurodegenerative diseases worldwide, affecting millions of people.
That's why we are evaluating new financing opportunities for smaller companies, specialised in exactly this area, to push forward the development of much needed therapies. Crowdfunding, where normal people pledge small contributions online, can be the way to go forward. Don't worry, we are not asking you for money.
If you can find 5 spare minutes to fill out a short questionnaire so we can better understand the environment we are working in, please click on the link to take part: https://www.surveymonkey.com/s/FYCNHNG